Zurich Cantonal Bank
ATRA icon

Zurich Cantonal Bank’s Atara Biotherapeutics ATRA Stock Holding History

Zurich Cantonal Bank’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-467
Closed -$33.9K – 2803
2023
Q1 		$33.9K Sell
467
-72
-13% -$6.98K ﹤0.01% 2680
2022
Q4 		$44.2K Buy
539
+117
+28% +$12.2K ﹤0.01% 2635
2022
Q3 		$40K Hold
422
– – ﹤0.01% 2657
2022
Q2 		$82K Sell
422
-9
-2% -$1.47K ﹤0.01% 2369
2022
Q1 		$100K Sell
431
-31
-7% -$9.87K ﹤0.01% 2289
2021
Q4 		$182K Sell
462
-9
-2% -$3.79K ﹤0.01% 2125
2021
Q3 		$211K Buy
471
+1
+0.2% +$358 ﹤0.01% 1887
2021
Q2 		$183K Buy
470
+9
+2% +$3.21K ﹤0.01% 1861
2021
Q1 		$165K Buy
461
+22
+5% +$9.72K ﹤0.01% 1892
2020
Q4 		$215K Sell
439
-70
-14% -$32.3K ﹤0.01% 1799
2020
Q3 		$165K Hold
509
– – ﹤0.01% 1737
2020
Q2 		$185K Buy
509
+330
+184% +$83.4K ﹤0.01% 1566
2020
Q1 		$38K Buy
179
+71
+66% +$22.5K ﹤0.01% 2064
2019
Q4 		$44K Hold
108
– – ﹤0.01% 2209
2019
Q3 		$38K Buy
108
+40
+59% +$14.9K ﹤0.01% 2195
2019
Q2 		$34K Hold
68
– – ﹤0.01% 2268
2019
Q1 		$67K Sell
68
-16
-19% -$14.9K ﹤0.01% 1822
2018
Q4 		$73K Hold
84
– – ﹤0.01% 1789
2018
Q3 		$87K Hold
84
– – ﹤0.01% 1798
2018
Q2 		$77K Hold
84
– – ﹤0.01% 1822
2018
Q1 		$82K Buy
+84
New +$76.5K ﹤0.01% 1715
2017
Q2 		– Sell
-256
Closed -$132K – 2528
2017
Q1 		$132K Buy
+256
New +$106K ﹤0.01% 1172

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Zurich Cantonal Bank's ATRA Position: Q2 2023 in Review

Zurich Cantonal Bank sold out of Atara Biotherapeutics (ATRA) in Q2 2023, closing a stake of 467 shares — an estimated $33.9K sold.

Zurich Cantonal Bank first reported a position in ATRA in Q1 2017 and held it in 22 quarters. The position peaked at $215K in Q4 2020. 118 funds tracked by Wall St. Rank hold ATRA as of Q2 2023.

  • Zurich Cantonal Bank reported no remaining Atara Biotherapeutics position as of Q2 2023 after selling out during the quarter.
  • Zurich Cantonal Bank sold 467 Atara Biotherapeutics shares in Q2 2023, an estimated $33.9K.
  • Zurich Cantonal Bank first reported a position in Atara Biotherapeutics in Q1 2017 and held it in 22 quarters.
  • Zurich Cantonal Bank's Atara Biotherapeutics position peaked at $215K in Q4 2020.
  • 118 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2023.

Based on Zurich Cantonal Bank's 13F filing for Q2 2023, filed 7 Aug 2023.